CEL-SCI CORPORATION
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.69B | ||||||
| 41.34B | ||||||
| 33.72B | ||||||
| 26.11B | ||||||
| 14.63B |
